Thulium laser transurethral vaporesection of the prostate and transurethral resection of the prostate for benign prostatic hyperplasia resulted in comparable improvements in International Prostate Symptom Score over 12 months.
The new guidance aims to support urologists and other clinicians in providing evidence-based care to their patients.
By watching what they eat and drink, patients can control such common problems as overactive bladder, prostatitis, interstitial cystitis, and chronic kidney disease.
Greater daily temperature differences, the average number of visits to emergency departments for lower urinary tract symptoms due to benign prostatic hyperplasia increase, according to a large study of Korean men.
Investigators found a significant positive correlation between transitional zone index (TZI) and IPSS and a significant negative correlation between TZI and both the International Index of Erectile Function and penile peak systolic velocity.
Aquablation therapy is associated with 3-year outcomes similar to those of transurethral resection of the prostate (TURP) for the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia (BPH), according to a new study. At 3 years, men who underwent Aquablation—a minimally invasive procedure in which a high-velocity waterjet is used to resect…
Complication and readmission rates for patients who undergo holmium laser enucleation of the prostate are similar whether patients are discharged directly from post-anesthesia care or are admitted to a hospital overnight, a study found.
New survey reveals low levels of awareness about prostate health in men older than 50 years of age
Neutrophil-to-lymphocyte ratio (NLR) may be useful as a surrogate marker of intravesical prostatic protrusion (IPP) in men with benign prostatic hyperplasia, according to a new report. IPP is an anatomical feature caused by the growth of prostatic lateral and median lobes. The new finding is from a study of 250 men older than 50 years…
Study of participants in the REDUCE trial found that statin use among dutasteride recipients was associated with a small but significant decrease in estimated mean prostate volume compared with nonuse over a 4-year period.
